Abstract
Over the past decade, scientists have already discovered several methods for cancer treatment, however, most of the treatments have various kinds of negative side effects. Researchers have focused on creating medications with few adverse effects for cancer because it is one of the most fatal diseases. Due to their anti-tumor properties and non-toxic attributes, bioactive macromolecules like polysaccharides are seen as viable options against cancer. Nowadays, there have been many studies on the mechanisms and possibilities of polysaccharides against tumors, and this paper attempts to summarize the progress and main problems achieved so far in polysaccharides against cancer. This article will start from these aspects, the idea of cancer treatment, how cancer affects the immune system, how polysaccharides are absorbed and processed, how they are used in anti-tumor therapy, and how they work are all covered in the current review. Future therapeutic research will place a high priority on polysaccharides since they have the potential to be significant therapeutic targets.
Publisher
Darcy & Roy Press Co. Ltd.
Reference15 articles.
1. National Cancer Institute. “What Is Cancer?” National Cancer Institute, Cancer.gov, 5 May 2021, www.cancer.gov/about-cancer/understanding/what-is-cancer.
2. Mayo Clinic. “Cancer Treatment - Mayo Clinic.” Mayoclinic.org, 4 June 2020, www.mayoclinic.org/tests-procedures/cancer-treatment/about/pac-20393344.
3. “Chemotherapy: What You Need to Know | UVA Health.” Uvahealth.com, uvahealth.com/services/cancer/chemotherapy.
4. Zeng, Yujun, et al. “Polysaccharide-Based Nanomedicines for Cancer Immunotherapy: A Review.” Bioactive Materials, vol. 6, no. 10, Oct. 2021, pp. 3358–3382, 10.1016/j.bioactmat.2021.03.008. Accessed 9 May 2022.
5. Ale, Marcel Tutor, et al. “Fucoidan from Sargassum Sp. And Fucus Vesiculosus Reduces Cell Viability of Lung Carcinoma and Melanoma Cells in Vitro and Activates Natural Killer Cells in Mice in Vivo.” International Journal of Biological Macromolecules, vol. 49, no. 3, 1 Oct. 2011, pp. 331–336, pubmed.ncbi.nlm.nih.gov/21624396/, 10.1016/j.ijbiomac.2011.05.009. Accessed 11 Nov. 2020.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献